4//SEC Filing
NAVIDEA BIOPHARMACEUTICALS, INC. 4
Accession 0001654954-17-005235
CIK 0000810509operating
Filed
May 30, 8:00 PM ET
Accepted
May 31, 5:28 PM ET
Size
4.3 KB
Accession
0001654954-17-005235
Insider Transaction Report
Form 4
Latkin Jed
Interim COO
Transactions
- Purchase
Common Stock, $.001 par value
2017-05-30$0.44/sh+7,600$3,317→ 50,159 total
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000810509
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 5:28 PM ET
- Size
- 4.3 KB